Typ 2 DiabetesT2DNCT07630025
Concurrent Exercise Training
A study testing Exercise in people with Typ 2 Diabetes, run by Prince Sattam Bin Abdulaziz University.
Trial summary
The goal of this clinical trial is to investigate the influence of morning versus evening concurrent training consisting of high-intensity interval training and resistance training on glycemic control in men with type 2 diabetes mellitus. Read more about this study
- Who is it for?
- Ages 40 to 60 years, men only
- Conditions the study is for
- Typ 2 Diabetes
- What is being tested?
- Exercise
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- No sites listed yet
- Study dates
- Jun 2026to Oct 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 60 years
- Men only
- No healthy volunteers
- Adult
Who may be able to join
- men aged 40-60 years with a diagnosis of T2D
- HbA1c levels between 7.0% and 9.0%
- treatment with oral hypoglycemic agents for at least 6 months
- a BMI <30 kg/m²
- a physically inactive
Who cannot join
- current insulin therapy
- a cardiovascular event within the previous 6 months
- cardiovascular, respiratory or musculoskeletal conditions that could limit participation in exercise training
- body weight instability
About this study
Official title: The Impact of Morning Versus Evening Concurrent High-Intensity Interval Training and Resistance Training on Glycemic Control in in Men With Type 2 Diabetes Mellitus: A Randomized Controlled Trial
The goal of this clinical trial is to investigate the influence of morning versus evening concurrent training consisting of high-intensity interval training and resistance training on glycemic control in men with type 2 diabetes mellitus. The main questions it aims to answer are:
- Which time is best for concurrent exercise training in diabetic patients, morning or evening? Researchers will compare morning versus evening concurrent training consisting of HIIT and RT on glycemic control in men with type 2 diabetes mellitus.
Read more
Participants will:
- Perform concurrent training consisting of high-intensity interval training and resistance training for 12 weeks
- Visit the clinic before and after the 12-week experimental period for checkups and tests
- Conditions
- Typ 2 Diabetes
- Being tested
- Exercise
- Keywords
- Diabetes, High Intensity Interval Trainin, resistance trsaining, glycemic control
- Medical subject headings
- Diabetes Mellitus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ExerciseBehavioural
Morning concurrent high-intensity interval training and resistance training
exerciseBehavioural
evening concurrent high-intensity interval training and resistance training between 16:00 and 19:00
| Study group | Role | What they receive |
|---|---|---|
| Morning concurrent training (amCT) | Experimental | will perform combined HIIT and RT between 06:00 and 09:00 Receives: Behavioral: Exercise |
| Evening concurrent training (pmCT) | Experimental | will perform combined HIIT and RT between 16:00 and 19:00 Receives: Behavioral: exercise |
| The control group (CON) | No intervention | no exercise program |
What is being measured
The primary outcome is the main question the study is designed to answer.
glycemic control
HbA1c
Measured: baseline and at 12 weeks.
Secondary outcomes (2)
lipid profile
total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides
Measured: baseline and at 12 weeks
cardiorespiratory fitness
VO2peak
Measured: at baseline and at 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jun 2026
- Study startJun 2026 (estimated)
- Primary completionSep 2026 (estimated)
- Study completionOct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Typ 2 DiabetesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Prince Sattam Bin Abdulaziz University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ahmad Saied Mohammad, Prince Sattam Bin Abdulaziz University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07630025
- Sponsor's protocol ID
- CT 2026
- Other IDs
- 2025/03/33413
- Acronym
- T2D
- Status last verified
- Jun 2026
- First submitted
- 1 Jun 2026
- Last updated
- 5 Jun 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: on request from the PA
Study at a glance
From the registry record, last updated by the sponsor on 5 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Impact of Morning Versus Evening Concurrent High-Intensity Interval Training and Resistance Training on Glycemic Control in in Men With Type 2 Diabetes Mellitus: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07630025
- Acronym / sponsor ID
- T2D / CT 2026
- Conditions
- Typ 2 Diabetes
- Keywords
- Diabetes, High Intensity Interval Trainin, resistance trsaining, glycemic control
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Prince Sattam Bin Abdulaziz UniversityUniversity, hospital or other
- Study start
- Jun 2026 (estimated)
- Primary completion
- Sep 2026 (estimated)
- Study completion
- Oct 2026 (estimated)
- First posted
- 5 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to investigate the influence of morning versus evening concurrent training consisting of high-intensity interval training and resistance training on glycemic control in men with type 2 diabetes mellitus. The main questions it aims to answer are:
- Which time is best for concurrent exercise training in diabetic patients, morning or evening? Researchers will compare morning versus evening concurrent training consisting of HIIT and RT on glycemic control in men with type 2 diabetes mellitus.
Participants will:
- Perform concurrent training consisting of high-intensity interval training and resistance training for 12 weeks
- Visit the clinic before and after the 12-week experimental period for checkups and tests
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Morning concurrent training (amCT) | Experimental | Behavioral: Exercisewill perform combined HIIT and RT between 06:00 and 09:00 |
| Evening concurrent training (pmCT) | Experimental | Behavioral: exercisewill perform combined HIIT and RT between 16:00 and 19:00 |
| The control group (CON) | No intervention | –no exercise program |
Who may qualify
- Ages
- 40 to 60 years
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- men aged 40-60 years with a diagnosis of T2D
- HbA1c levels between 7.0% and 9.0%
- treatment with oral hypoglycemic agents for at least 6 months
- a BMI <30 kg/m²
- a physically inactive
Key exclusion criteria (4 listed)
- current insulin therapy
- a cardiovascular event within the previous 6 months
- cardiovascular, respiratory or musculoskeletal conditions that could limit participation in exercise training
- body weight instability
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ExerciseMorning concurrent high-intensity interval training and resistance training | Behavioural | Morning concurrent training (amCT) |
| exerciseevening concurrent high-intensity interval training and resistance training between 16:00 and 19:00 | Behavioural | Evening concurrent training (pmCT) |
Primary outcome
glycemic control
Time frame: baseline and at 12 weeks.
HbA1c
2 secondary outcomes
lipid profile
Time frame: baseline and at 12 weeks
cardiorespiratory fitness
Time frame: at baseline and at 12 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Jun 2026.
- Individual participant dataSharing planned: Yes. on request from the PA
Related trials for Typ 2 Diabetes
Recruiting
Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure
Hypertension, Systolic, Metabolic Syndrome
Recruiting
The eHealth Diabetes Remission Trial
Diabetes Mellitus, Type 2
Not yet recruiting
Multicentric Approval Study Trans-Duodenal Barrier for Typ 2 Diabetes With Obesity
Typ 2 Diabetes, Obesity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Exercise in people with Typ 2 Diabetes, run by Prince Sattam Bin Abdulaziz University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 5 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
glycemic control (time frame: baseline and at 12 weeks.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2026.